Kaya, A. O. Et Al. 2012. Efficacy and Toxicity of Gemcitabine Plus Docetaxel Combination as a Second Line Therapy for Patients with Advanced Stage Soft Tissue Sarcoma. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.2 , 463-467.

Kaya, A. O., Buyukberber, S., ÖZKAN, M., Alkis, N., Sevinc, A., Ozdemir, N. Y., ... Alici, S.(2012). Efficacy and Toxicity of Gemcitabine Plus Docetaxel Combination as a Second Line Therapy for Patients with Advanced Stage Soft Tissue Sarcoma. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.2, 463-467.

Kaya, Ali Et Al. "Efficacy and Toxicity of Gemcitabine Plus Docetaxel Combination as a Second Line Therapy for Patients with Advanced Stage Soft Tissue Sarcoma," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.2, 463-467, 2012

Kaya, Ali O. Et Al. "Efficacy and Toxicity of Gemcitabine Plus Docetaxel Combination as a Second Line Therapy for Patients with Advanced Stage Soft Tissue Sarcoma." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.2, pp.463-467, 2012

Kaya, A. O. Et Al. (2012) . "Efficacy and Toxicity of Gemcitabine Plus Docetaxel Combination as a Second Line Therapy for Patients with Advanced Stage Soft Tissue Sarcoma." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.2, pp.463-467.

@article{article, author={Ali Osman Kaya Et Al. }, title={Efficacy and Toxicity of Gemcitabine Plus Docetaxel Combination as a Second Line Therapy for Patients with Advanced Stage Soft Tissue Sarcoma}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2012, pages={463-467} }